Latest filing published 10 Jun 2025 for Context Therapeutics Inc., €10k.
Filing timeline
BuySaleInsider track record
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Alex C. Levit: trading record in brief
Alex C. Levit appears in our data through filings on Context Therapeutics Inc. shares, published by SEC (Form 4). Over a trading history stretching from 22 October 2021 to 6 June 2025, the count stands at 3 filings.
The open-market record is one-sided, with 3 purchases worth €28k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2025: 1 purchase and no sales on the market.
The median purchase comes to €10k. On 2 out of 3 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The newest entry dates from 10 June 2025: an open-market purchase of €10k, in Context Therapeutics Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Alex C. Levit
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ US$0.57636.2% of flowCommon StockSEC:0001842952-25-000062:0Canonical exit: 4 Sept 2025 (T+90)
- 6,000 shares@ US$0.849115.8% of flowCommon StockSEC:0001842952-22-000110:0Canonical exit: 9 Mar 2023 (T+90)
- 3,000 shares@ US$5.0046.4% of flowCommon StockSEC:0001179110-21-009610:0Canonical exit: 20 Jan 2022 (T+90)
3 of 3 declarations